Mechanism and prospects of mitochondrial transplantation for spinal cord injury treatment
- PMID: 39609871
- PMCID: PMC11606159
- DOI: 10.1186/s13287-024-04077-5
Mechanism and prospects of mitochondrial transplantation for spinal cord injury treatment
Abstract
Spinal cord injury (SCI) involves a continuous and dynamic cascade of complex reactions, with mitochondrial damage and dysfunction-induced energy metabolism disorders playing a central role throughout the process. These disorders not only determine the severity of secondary injuries but also influence the potential for axonal regeneration. Given the critical role of energy metabolism disturbances in the pathology of SCI, strategies such as enhancing mitochondrial transport within axons to alleviate local energy deficits, or transplanting autologous or allogeneic mitochondria to restore energy supply to damaged tissues, have emerged as potential approaches for SCI repair. These strategies also aim to modulate local inflammatory responses and apoptosis. Preclinical studies have initially demonstrated that mitochondrial transplantation (MT) significantly reduces neuronal death and promotes axonal regeneration following spinal cord injury. MT achieves this by regulating signaling pathways such as MAPK/ERK and PI3K/Akt, promoting the expression of growth-associated protein-43 (GAP-43) in neurons, and inhibiting the expression of apoptosis-related proteins like Grp78, Chop, and P-Akt, thereby enhancing the survival and regeneration of damaged neurons. Additionally, MT plays a role in promoting the expression of vascular endothelial growth factor, facilitating tissue repair, and reducing the secretion of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Furthermore, MT modulates neuronal apoptosis and inflammatory responses by decreasing the expression of p-JNK, a member of the MAPK family. In summary, by reviewing the detailed mechanisms underlying the cascade of pathological processes in SCI, we emphasize the changes in endogenous mitochondria post-SCI and the potential of exogenous MT in SCI repair. This review aims to provide insights and a basis for developing more effective clinical treatments for SCI.
Keywords: Advancements; Mechanisms; Mitochondrial transplantation; Pathological cascade reactions; Spinal cord injury.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: All authors confirm their consent for publication. Competing interests: The authors declare that they have no competing interests.
Figures


Similar articles
-
HGFIN deficiency exacerbates spinal cord injury by promoting inflammation and cell apoptosis through regulation of the PI3K/AKT signaling pathway.Adv Clin Exp Med. 2024 Sep;33(9):929-940. doi: 10.17219/acem/174004. Adv Clin Exp Med. 2024. PMID: 38014930
-
The study of traditional Chinese medical elongated-needle therapy promoting neurological recovery mechanism after spinal cord injury in rats.J Ethnopharmacol. 2016 Jul 1;187:28-41. doi: 10.1016/j.jep.2016.04.019. Epub 2016 Apr 13. J Ethnopharmacol. 2016. PMID: 27085942
-
Mitochondrial dynamics reveal potential to facilitate axonal regeneration after spinal cord injury.J Transl Med. 2025 Jun 2;23(1):617. doi: 10.1186/s12967-025-06611-2. J Transl Med. 2025. PMID: 40457377 Free PMC article. Review.
-
Bone marrow mesenchymal stem cells modulate miR-202-3p to suppress neuronal apoptosis following spinal cord injury through autophagy activation via the AMPK, MAPK, and PI3K/AKT/mTOR signaling pathway.Sci Rep. 2024 Dec 3;14(1):30099. doi: 10.1038/s41598-024-81332-y. Sci Rep. 2024. PMID: 39627300 Free PMC article.
-
Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury.Stem Cell Res Ther. 2021 Jan 7;12(1):36. doi: 10.1186/s13287-020-02090-y. Stem Cell Res Ther. 2021. PMID: 33413653 Free PMC article. Review.
Cited by
-
A Review of Pathophysiology, Molecular Mechanisms, and Omics Approaches of Spinal Cord Injury.Int J Mol Sci. 2025 Aug 15;26(16):7895. doi: 10.3390/ijms26167895. Int J Mol Sci. 2025. PMID: 40869215 Free PMC article. Review.
-
Exosomes: a promising microenvironment modulator for spinal cord injury treatment.Int J Biol Sci. 2025 Jun 5;21(8):3791-3824. doi: 10.7150/ijbs.115242. eCollection 2025. Int J Biol Sci. 2025. PMID: 40520019 Free PMC article. Review.
-
Mesenchymal stem cell exosomes therapy for the treatment of traumatic brain injury: mechanism, progress, challenges and prospects.J Transl Med. 2025 Apr 11;23(1):427. doi: 10.1186/s12967-025-06445-y. J Transl Med. 2025. PMID: 40217480 Free PMC article. Review.
-
Antioxidant nanozymes: current status and future perspectives in spinal cord injury treatments.Theranostics. 2025 May 8;15(13):6146-6183. doi: 10.7150/thno.114836. eCollection 2025. Theranostics. 2025. PMID: 40521206 Free PMC article. Review.
-
Advances in brain remodeling, stem cell therapies, and translational barriers in stroke and brain aging.Biogerontology. 2025 Jul 11;26(4):143. doi: 10.1007/s10522-025-10282-3. Biogerontology. 2025. PMID: 40643679 Free PMC article. Review.
References
-
- Shang Z, Wanyan P, Wang M, Zhang B, Cui X, Wang X. Stem cell-derived exosomes for traumatic spinal cord injury: a systematic review and network meta-analysis based on a rat model. Cytotherapy. 2024;26(1):1–10. - PubMed
-
- Satrústegui J, Pardo B, Del Arco A. Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev. 2007;87(1):29–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous